Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.

Zou YQ, Lu LJ, Li SJ, Zeng T, Wang XD, Bao CD, Chen SL, Yang CD.

Clin Biochem. 2008 May;41(7-8):519-24. doi: 10.1016/j.clinbiochem.2008.01.008. Epub 2008 Jan 26.

PMID:
18261992
2.

Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.

Jung SY, Park YB, Ha YJ, Lee KH, Lee SK.

J Rheumatol. 2010 May;37(5):1029-34. doi: 10.3899/jrheum.091120. Epub 2010 Mar 15.

PMID:
20231196
3.
5.

A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.

Wang FF, Huang XF, Shen N, Leng L, Bucala R, Chen SL, Lu LJ.

Arthritis Res Ther. 2013;15(3):R65.

6.

Increased serum vitamin B12 levels are associated with adult-onset Still's disease with reactive macrophage activation syndrome.

Kalyoncu U, Buyukasik Y, Akdogan A, Karadag O, Bilgen SA, Kiraz S, Ertenli I, Calguneri M.

Joint Bone Spine. 2010 Mar;77(2):131-4. doi: 10.1016/j.jbspin.2009.09.010. Epub 2010 Feb 6.

PMID:
20138793
7.
8.

Serum cytokine profiles in patients with adult onset Still's disease.

Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, Nahm DH, Park HS.

J Rheumatol. 2003 Nov;30(11):2422-7.

PMID:
14677188
9.
10.

Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.

Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N.

J Rheumatol. 2010 Nov;37(11):2369-76. doi: 10.3899/jrheum.100247. Epub 2010 Sep 1.

PMID:
20810496
11.

Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.

Bae CB, Suh CH, An JM, Jung JY, Jeon JY, Nam JY, Kim HA.

J Rheumatol. 2014 Dec;41(12):2403-8. doi: 10.3899/jrheum.140651. Epub 2014 Oct 1.

PMID:
25274901
12.

Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.

Kim HA, An JM, Nam JY, Jeon JY, Suh CH.

J Rheumatol. 2012 Jul;39(7):1399-406. doi: 10.3899/jrheum.120079. Epub 2012 Jun 1. Erratum in: J Rheumatol. 2014 Jun;41(6):1255.

PMID:
22660800
13.
14.

Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria.

Gambichler T, Paech V, Rotterdam S, Stücker M, Boms S, Altmeyer P.

Eur J Med Res. 2003 Dec 9;8(12):527-30.

PMID:
14711598
15.
16.

[Still's syndrome in the adult (adult-onset Still's disease). 2 case reports and review of the literature].

Hippke WE, Blasum CP, Barth J.

Hautarzt. 1994 Oct;45(10):711-5. Review. German.

PMID:
8002340
17.

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.

Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N.

Arthritis Rheum. 2001 Jul;44(7):1716-7. No abstract available.

18.

[Ferritin levels in adult Still's disease].

Flatau E, Reichman N, Kaufman N.

Harefuah. 1999 Sep;137(5-6):200-1, 263, 262. Hebrew.

PMID:
10959321
19.

Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.

Becker H, Gaubitz M, Domschke W, Willeke P.

Scand J Rheumatol. 2009 Jan-Feb;38(1):69-71. doi: 10.1080/03009740802179701. No abstract available.

PMID:
18686192
20.

Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.

Jung KH, Kim JJ, Lee JS, Park W, Kim TH, Jun JB, Yoo DH.

Scand J Rheumatol. 2014;43(2):162-9. doi: 10.3109/03009742.2013.824023. Epub 2013 Oct 18.

PMID:
24134323

Supplemental Content

Support Center